DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A••••• A•••••••• I••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: A•••••; A••••• Bidco LTD; A••••• Borrower LLC
Principal held
at least $38.7M
sum of BDC pieces, a lower bound
Fair value
$40.6M
100c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
4
3 on the latest quarter
Facilities
2
1 equity pieces beside them
Next maturity
Dec 31, 2031
no dated debt inside 24 months
On the tape since
Sep 30, 2022
latest Jun 30, 2026
Events
8
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $38.7M | 100c | SOFR+450 bp | Jun 18, 2033 | 4 |
| first lien revolver first lien | at least $0 | n/a | SOFR+450 bp | Jun 18, 2033 | 4 |
Equity pieces beside the debt: equity ($4,749 fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | revolver first lien Investment T••• 1st L••• R••••••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D•• | $0 | $0 0c | SOFR+450 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• S••••• S•••••• R•••••••• Credit L••• I•••• S+ S••••• 4.50% I••••••• R••• 8 | n/a | n/a | SOFR+450 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D• | $415,625 | $412,508 100c | SOFR+450 bp |
| A•••• C••••• B•• I••• | equity equity Investment T••• C•••• A-1 U•••• A••••••••• D••• 12/30/2025 | n/a | $4,749 97c | |
| A•••• P•••••• C••••• F•••• L•• | revolver first lien Investment T••• 1st L••• R••••••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D•• | $0 | $0 0c | SOFR+450 bp |
| A•••• P•••••• C••••• F•••• L•• | revolver first lien 1st L••• R••••••• M••••••• 12/31/2031 | n/a | n/a | SOFR+450 bp |
| A•••• P•••••• C••••• F•••• L•• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D• | $7.5M | $7.4M 100c | SOFR+450 bp |
| B•••••••• P•••••• C••••• F••• | term loan first lien I••••••••• F•••• L••• T••• L••• Ref E••••••(Q) F•••• 0.75% S••••• 4.50% T•••• C••••• 6.91% | $16.2M | $18.3M 100c | EURIBOR+450 bp |
| B•••••••• P•••••• C••••• F••• | revolver first lien I••••••••• F•••• L••• R••••••• Ref S•••(Q) F•••• 0.75% S••••• 4.50% T•••• C••••• 8.17% M•• | $0 | $-81,028 101c | SOFR+450 bp |
| B•••••••• P•••••• C••••• F••• | term loan first lien I••••••••• F•••• L••• T••• L••• Ref S•••(Q) F•••• 0.75% S••••• 4.50% T•••• C••••• 8.17% M• | $14.6M | $14.5M 100c | SOFR+450 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 3 | $38.7M | $40.6M | 100c | 0 |
| Mar 31, 2026 | 2 | $7.5M | $7.4M | 100c | 0 |
| Dec 31, 2025 | 2 | $15.4M | $15.2M | 100c | 0 |
| Sep 30, 2025 | 1 | $20.1M | $20.1M | 101c | 0 |
| Jun 30, 2025 | 1 | $20.1M | $20.0M | 100c | 0 |
| Mar 31, 2025 | 1 | $20.1M | $19.9M | 100c | 0 |
| Dec 31, 2024 | 3 | $20.2M | $19.7M | 99c | 0 |
| Sep 30, 2024 | 1 | $20.2M | $20.0M | 100c | 0 |
| Jun 30, 2024 | 1 | $20.2M | $20.2M | 101c | 0 |
| Mar 31, 2024 | 1 | $20.3M | $20.3M | 101c | 0 |
| Dec 31, 2023 | 1 | $33.9M | $32.9M | 98c | 0 |
| Sep 30, 2023 | 1 | $19.5M | $19.1M | 99c | 0 |
| Jun 30, 2023 | 1 | $17.9M | $17.3M | 98c | 0 |
| Mar 31, 2023 | 1 | $27.9M | $27.6M | 100c | 0 |
| Dec 31, 2022 | 1 | $51.3M | $50.6M | 100c | 0 |
| Sep 30, 2022 | 1 | $25.7M | $25.1M | 99c | 0 |
What changed
- New lender joined a facilityJun 30, 2026
- Maturity extended (observed)Jun 30, 2026
- New lender joined a facilityJun 30, 2026
- Maturity extended (observed)Jun 30, 2026
- Spread changed (observed)Dec 31, 2025
- Maturity extended (observed)Dec 31, 2025
- New lender joined a facilityDec 31, 2025
- New lender joined a facilityDec 31, 2025
- Spread changed (observed)Dec 31, 2025
- Maturity extended (observed)Dec 31, 2025
- Lender left a facilitySep 30, 2025
- Lender left a facilitySep 30, 2025
- Maturity extended (observed)Dec 31, 2024
- New lender joined a facilityDec 31, 2024
- Marked down (one lender)Mar 31, 2023
- New borrower on a BDC scheduleSep 30, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- AVALONderivedthe codename stem after legal suffixes and deal words
- Spellings
- 3 across 4 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it